FPXE.US First Trust IPOX Europe Equity Opportunities ETF
- Total assets
- 4.79M
- Expense ratio
- 0.67%
- Dividend yield
- 1.82%
- 1-year return
- +4.93%
- Holdings
- 100
- Since
- 2018
Fund data as reported by the issuer, updated Nov 13, 2026. Total assets are in the fund's base currency.
What does FPXE.US invest in?
- Mostly Non-US stocks (88.3%)
- Largest sector: Healthcare (30.1%)
- Largest region: Europe Developed (76.2%)
- Top 3 holdings: 21.4% of the fund
Asset allocation
- Non-US stocks 88.3%
- US stocks 15.9%
- Cash 0.1%
Top holdings
- Roche Holding AG 7.99%
- Swedish Orphan Biovitrum AB (publ) 6.95%
- BAWAG Group AG 6.51%
- Ascendis Pharma AS 6.42%
- Nordnet AB 6.18%
First Trust IPOX Europe Equity Opportunities ETF performance
Sharpe ratio 0.88- This year
- +2.53%
- 1 year
- +4.93%
- 3 years
- +18.40%
- 5 years
- +1.30%
Volatility 16.5% over 1 year and 15.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
FPXE.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About First Trust IPOX Europe Equity Opportunities ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index seeks to measure the performance of the equity securities of the 100 largest and typically most liquid initial public offerings (IPOs) (including spin-offs and equity carve-outs) of companies that are economically tied to Europe. The fund is non-diversified.
Full fund profileFirst Trust IPOX Europe Equity Opportunities ETF top holdings
53.4% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 7.99% |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | Healthcare | Sweden | 6.95% |
| BAWAG Group AG BG.VI | Financial Services | Austria | 6.51% |
| Ascendis Pharma AS ASND.US | Healthcare | United States | 6.42% |
| Nordnet AB SAVE.ST | Financial Services | Sweden | 6.18% |
| Lottomatica Group S.p.A. LTMC.MI | Consumer Cyclical | Italy | 5.63% |
| Technoprobe SpA TPRO.MI | Technology | Italy | 4.53% |
| Andritz AG ANDR.VI | Industrials | Austria | 3.23% |
| Arm Holdings plc American Depositary Shares ARM.US | Technology | United States | 3.09% |
| Sandoz Group AG SDZ.SW | Healthcare | Switzerland | 2.89% |
The 10 largest of 100 holdings.
FPXE.US sector exposure
- Healthcare30.1%
- Financial Services22.8%
- Consumer Cyclicals10.5%
- Industrials9.6%
- Technology9.6%
- Energy7.1%
- Basic Materials5.4%
- Communication Services2.1%
- Consumer Defensive2.0%
- Real Estate0.2%
Share of the stocks in the fund.
FPXE.US regional exposure
- Europe Developed76.2%
- North America15.2%
- United Kingdom8.8%
- Africa/Middle East0.9%
- Europe Emerging0.5%
- Latin America0.1%
- Asia Emerging0.1%
Share of the stocks in the fund.
Company size
Average market cap 18.1B- Mega cap14.8%
- Big cap13.9%
- Medium cap56.3%
- Small cap8.8%
- Micro cap1.4%
First Trust IPOX Europe Equity Opportunities ETF fund profile
- Fund name
- First Trust IPOX Europe Equity Opportunities ETF
- Ticker
- FPXE.US
- Exchange
- USA Stocks
- Issuer
- First Trust
- Index tracked
- -
- Category
- Europe Equity
- Inception date
- Oct 4, 2018
- Trading currency
- USD
- Expense ratio
- 0.67%
- Annual turnover
- 1.2%
About First Trust IPOX Europe Equity Opportunities ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index seeks to measure the performance of the equity securities of the 100 largest and typically most liquid initial public offerings (IPOs) (including spin-offs and equity carve-outs) of companies that are economically tied to Europe. The fund is non-diversified.